Skip to main content
. 2016 Oct 4;87(14):1464–1472. doi: 10.1212/WNL.0000000000003169

Figure 4. Median percentage change in brain parenchymal fraction in (A) CARE-MS I and (B) CARE-MS II.

Figure 4

Data are shown as medians with standard error bars; p values are for the comparison of alemtuzumab with SC IFN-β-1a over the time period shown. CARE-MS = Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis; NS = no significant difference; SC IFN-β-1a = subcutaneous interferon β-1a.